US Patent Number
Optically active nornicotine compounds as a treatment for dopamine-related conditions and disease states. Such disease states include the treatment of myasthenia gravis, Parkinson's disease, Alzheimer's disease, schizophrenia, eating disorders, ulcers, drug addiction and as a substitute for psycho-stimulant self-administration.
University of Kentucky Research Foundation, Lexington, Ky.
Crooks, Peter A.; Dwoskin, Linda Phyliss; and Bardo, Michael Thomas, "Nornicotine Enantiomers for Use as a Treatment for Dopamine Related Conditions and Disease States" (1998). Pharmaceutical Sciences Faculty Patents. 109.